385 related articles for article (PubMed ID: 34885733)
1. Treatment of Benign Prostatic Hyperplasia by Natural Drugs.
Csikós E; Horváth A; Ács K; Papp N; Balázs VL; Dolenc MS; Kenda M; Kočevar Glavač N; Nagy M; Protti M; Mercolini L; Horváth G; Farkas Á; On Behalf Of The Oemonom
Molecules; 2021 Nov; 26(23):. PubMed ID: 34885733
[TBL] [Abstract][Full Text] [Related]
2. Phytotherapy for benign prostatic hyperplasia.
Wilt TJ; Ishani A; Rutks I; MacDonald R
Public Health Nutr; 2000 Dec; 3(4A):459-72. PubMed ID: 11276294
[TBL] [Abstract][Full Text] [Related]
3. Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia.
Bartsch G; Rittmaster RS; Klocker H
World J Urol; 2002 Apr; 19(6):413-25. PubMed ID: 12022710
[TBL] [Abstract][Full Text] [Related]
4. Nutraceutical treatment and prevention of benign prostatic hyperplasia and prostate cancer.
Cicero AFG; Allkanjari O; Busetto GM; Cai T; Larganà G; Magri V; Perletti G; Robustelli Della Cuna FS; Russo GI; Stamatiou K; Trinchieri A; Vitalone A
Arch Ital Urol Androl; 2019 Oct; 91(3):. PubMed ID: 31577095
[TBL] [Abstract][Full Text] [Related]
5. What do we know about phytotherapy of benign prostatic hyperplasia?
Allkanjari O; Vitalone A
Life Sci; 2015 Apr; 126():42-56. PubMed ID: 25703069
[TBL] [Abstract][Full Text] [Related]
6. Future aspects of plant derived bioactive metabolites as therapeutics to combat benign prostatic hyperplasia.
Krishnamoorthi R; Ganapathy A A; Hari Priya VM; Kumaran A
J Ethnopharmacol; 2024 Aug; 330():118207. PubMed ID: 38636573
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of Ponciri Fructus on testosterone-induced benign prostatic hyperplasia in rats.
Jeon WY; Kim OS; Seo CS; Jin SE; Kim JA; Shin HK; Kim YU; Lee MY
BMC Complement Altern Med; 2017 Aug; 17(1):384. PubMed ID: 28774334
[TBL] [Abstract][Full Text] [Related]
8. A phytosterol-enriched saw palmetto supercritical CO
Sudeep HV; Venkatakrishna K; Amrutharaj B; Anitha ; Shyamprasad K
BMC Complement Altern Med; 2019 Oct; 19(1):270. PubMed ID: 31623582
[TBL] [Abstract][Full Text] [Related]
9. Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia.
Bartsch G; Rittmaster RS; Klocker H
Eur Urol; 2000 Apr; 37(4):367-80. PubMed ID: 10765065
[TBL] [Abstract][Full Text] [Related]
10. Serenoa Repens, lycopene and selenium: a triple therapeutic approach to manage benign prostatic hyperplasia.
Minutoli L; Bitto A; Squadrito F; Marini H; Irrera N; Morgia G; Passantino A; Altavilla D
Curr Med Chem; 2013; 20(10):1306-12. PubMed ID: 23432584
[TBL] [Abstract][Full Text] [Related]
11. Effects of long-term treatment with Serenoa repens (Permixon) on the concentrations and regional distribution of androgens and epidermal growth factor in benign prostatic hyperplasia.
Di Silverio F; Monti S; Sciarra A; Varasano PA; Martini C; Lanzara S; D'Eramo G; Di Nicola S; Toscano V
Prostate; 1998 Oct; 37(2):77-83. PubMed ID: 9759701
[TBL] [Abstract][Full Text] [Related]
12. Cynomorium songaricum Rupr demonstrates phytoestrogenic or phytoandrogenic like activities that attenuates benign prostatic hyperplasia via regulating steroid 5-α-reductase.
Tao R; Miao L; Yu X; Orgah JO; Barnabas O; Chang Y; Liu E; Fan G; Gao X
J Ethnopharmacol; 2019 May; 235():65-74. PubMed ID: 30708032
[TBL] [Abstract][Full Text] [Related]
13. Phytotherapy for benign prostatic hyperplasia.
Gerber GS
Curr Urol Rep; 2002 Aug; 3(4):285-91. PubMed ID: 12149159
[TBL] [Abstract][Full Text] [Related]
14. Redesigning a large-scale clinical trial in response to negative external trial results: the CAMUS study of phytotherapy for benign prostatic hyperplasia.
Lee J; Andriole G; Avins A; Crawford ED; Foster H; Kaplan S; Kreder K; Kusek J; McCullough A; McVary K; Meleth S; Naslund M; Nickel JC; Nyberg L; Roehrborn C; Dale Williams O; Barry M
Clin Trials; 2009 Dec; 6(6):628-36. PubMed ID: 20007408
[TBL] [Abstract][Full Text] [Related]
15. [Natural 5α-reductase inhibitors in treatment of benign prostatic hyperplasia].
Zheng RR; Ouyang QX; Liu ZY; Li LN; Yang L; Wang ZT
Zhongguo Zhong Yao Za Zhi; 2024 Feb; 49(4):858-867. PubMed ID: 38621893
[TBL] [Abstract][Full Text] [Related]
16. Anti-Proliferative Effects of HBX-5 on Progression of Benign Prostatic Hyperplasia.
Jin BR; Kim HJ; Park SK; Kim MS; Lee KH; Yoon IJ; An HJ
Molecules; 2018 Oct; 23(10):. PubMed ID: 30322186
[TBL] [Abstract][Full Text] [Related]
17. Effect of D-004, a lipid extract from the Cuban royal palm fruit, on atypical prostate hyperplasia induced by phenylephrine in rats.
Arruzazabala ML; Más R; Molina V; Noa M; Carbajal D; Mendoza N
Drugs R D; 2006; 7(4):233-41. PubMed ID: 16784248
[TBL] [Abstract][Full Text] [Related]
18. Quisqualis indica Improves Benign Prostatic Hyperplasia by Regulating Prostate Cell Proliferation and Apoptosis.
Ub Wijerathne C; Park HS; Jeong HY; Song JW; Moon OS; Seo YW; Won YS; Son HY; Lim JH; Yeon SH; Kwun HJ
Biol Pharm Bull; 2017 Dec; 40(12):2125-2133. PubMed ID: 28943529
[TBL] [Abstract][Full Text] [Related]
19. Tissue effects of saw palmetto and finasteride: use of biopsy cores for in situ quantification of prostatic androgens.
Marks LS; Hess DL; Dorey FJ; Luz Macairan M; Cruz Santos PB; Tyler VE
Urology; 2001 May; 57(5):999-1005. PubMed ID: 11337315
[TBL] [Abstract][Full Text] [Related]
20. Differential effect of finasteride on the tissue androgen concentrations in benign prostatic hyperplasia.
Habib FK; Ross M; Tate R; Chisholm GD
Clin Endocrinol (Oxf); 1997 Feb; 46(2):137-44. PubMed ID: 9135694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]